Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Similar articles for PubMed (Select 23950874)

1.

CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.

Knight A, Arnouk H, Britt W, Gillespie GY, Cloud GA, Harkins L, Su Y, Lowdell MW, Lamb LS.

PLoS One. 2013 Aug 7;8(8):e68729. doi: 10.1371/journal.pone.0068729. eCollection 2013.

2.

Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy.

Lamb LS Jr, Bowersock J, Dasgupta A, Gillespie GY, Su Y, Johnson A, Spencer HT.

PLoS One. 2013;8(1):e51805. doi: 10.1371/journal.pone.0051805. Epub 2013 Jan 11.

3.

Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.

Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, Langford CP, Arnouk H, Su Y, Haines HL, Suarez-Cuervo C, Lamb LS Jr.

J Neurooncol. 2011 Jan;101(2):179-88. doi: 10.1007/s11060-010-0245-2. Epub 2010 Jun 10.

PMID:
20532954
4.

Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.

Halary F, Pitard V, Dlubek D, Krzysiek R, de la Salle H, Merville P, Dromer C, Emilie D, Moreau JF, Déchanet-Merville J.

J Exp Med. 2005 May 16;201(10):1567-78.

5.

Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.

Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, Meleth S, Lopez RD, Lamb LS Jr.

Neuro Oncol. 2009 Aug;11(4):357-67. doi: 10.1215/15228517-2008-111. Epub 2009 Feb 11.

6.

Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.

Nair SK, De Leon G, Boczkowski D, Schmittling R, Xie W, Staats J, Liu R, Johnson LA, Weinhold K, Archer GE, Sampson JH, Mitchell DA.

Clin Cancer Res. 2014 May 15;20(10):2684-94. doi: 10.1158/1078-0432.CCR-13-3268. Epub 2014 Mar 21.

7.

Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.

Alejenef A, Pachnio A, Halawi M, Christmas SE, Moss PA, Khan N.

Clin Exp Immunol. 2014 Jun;176(3):418-28. doi: 10.1111/cei.12297.

8.

Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.

Devaud C, Rousseau B, Netzer S, Pitard V, Paroissin C, Khairallah C, Costet P, Moreau JF, Couillaud F, Dechanet-Merville J, Capone M.

Cancer Immunol Immunother. 2013 Jul;62(7):1199-210. doi: 10.1007/s00262-013-1402-1. Epub 2013 Apr 26.

PMID:
23619975
9.

Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells.

Knight A, Mackinnon S, Lowdell MW.

Cytotherapy. 2012 Oct;14(9):1110-8. doi: 10.3109/14653249.2012.700766. Epub 2012 Jul 17.

PMID:
22800570
10.

Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.

Siegers GM, Dhamko H, Wang XH, Mathieson AM, Kosaka Y, Felizardo TC, Medin JA, Tohda S, Schueler J, Fisch P, Keating A.

Cytotherapy. 2011 Jul;13(6):753-64. doi: 10.3109/14653249.2011.553595. Epub 2011 Feb 11.

PMID:
21314241
11.

Skewed T cell receptor repertoire of Vdelta1(+) gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction.

Fujishima N, Hirokawa M, Fujishima M, Yamashita J, Saitoh H, Ichikawa Y, Horiuchi T, Kawabata Y, Sawada KI.

Clin Exp Immunol. 2007 Jul;149(1):70-9. Epub 2007 Apr 11.

12.

Implication of gammadelta T cells in the human immune response to cytomegalovirus.

Déchanet J, Merville P, Lim A, Retière C, Pitard V, Lafarge X, Michelson S, Méric C, Hallet MM, Kourilsky P, Potaux L, Bonneville M, Moreau JF.

J Clin Invest. 1999 May 15;103(10):1437-49.

13.

Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.

Nakazawa T, Nakamura M, Park YS, Motoyama Y, Hironaka Y, Nishimura F, Nakagawa I, Yamada S, Matsuda R, Tamura K, Sugimoto T, Takeshima Y, Marutani A, Tsujimura T, Ouji N, Ouji Y, Yoshikawa M, Nakase H.

J Neurooncol. 2014 Jan;116(1):31-9. doi: 10.1007/s11060-013-1258-4. Epub 2013 Sep 24.

PMID:
24062140
14.

Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.

Devaud C, Bilhere E, Loizon S, Pitard V, Behr C, Moreau JF, Dechanet-Merville J, Capone M.

Cancer Res. 2009 May 1;69(9):3971-8. doi: 10.1158/0008-5472.CAN-08-3037. Epub 2009 Apr 21.

15.

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, Powell SZ, Grossman R, Grada Z, Scheurer ME, Hegde M, Leen AM, Bollard CM, Rooney CM, Heslop HE, Gottschalk S, Ahmed N.

J Immunother. 2012 Feb-Mar;35(2):159-68. doi: 10.1097/CJI.0b013e318247642f.

16.

Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection.

Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME, Merville P, Moreau JF, Déchanet-Merville J.

Blood. 2008 Aug 15;112(4):1317-24. doi: 10.1182/blood-2008-01-136713. Epub 2008 Jun 6.

17.

Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.

Crough T, Beagley L, Smith C, Jones L, Walker DG, Khanna R.

Immunol Cell Biol. 2012 Oct;90(9):872-80. doi: 10.1038/icb.2012.19. Epub 2012 Apr 17.

PMID:
22508289
18.

Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

Maeurer MJ, Martin D, Walter W, Liu K, Zitvogel L, Halusczcak K, Rabinowich H, Duquesnoy R, Storkus W, Lotze MT.

J Exp Med. 1996 Apr 1;183(4):1681-96.

19.

The detection of CMV pp65 and IE1 in glioblastoma multiforme.

Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C.

J Neurooncol. 2011 Jun;103(2):231-8. doi: 10.1007/s11060-010-0383-6. Epub 2010 Sep 5.

PMID:
20820869
20.

Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.

Schilbach K, Frommer K, Meier S, Handgretinger R, Eyrich M.

J Immunother. 2008 Nov-Dec;31(9):896-905. doi: 10.1097/CJI.0b013e31818955ad.

PMID:
18832998
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk